CHKP Check Point posts 206 percent Q4 2025 EPS beat shares register 064 percent gain in todays trading Vertex Pharmaceuticals Incorporated VRTX Casgevy Commercial Momentum and Pipeline Catalysts Signal Upside Ahead of Partner CRISPR Therapeutics Q1 2026 Earnings PMT PennyMac reports Q4 2025 earnings per share 197 percent above estimates shares rise 142 percent today SCCF Sachem Q4 2025 earnings vastly beat analyst expectations with shares remaining flat in regular session trading DAL Delta Air posts 107 percent EPS upside surprise in Q1 2026 stock registers mild postearnings gains